Jennifer A. Webster, MS

Articles by Jennifer A. Webster, MS

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study

ByKatrina A.B. Goddard, PhD,Erin J. Aiello Bowles, MPH,Heather Spencer Feigelson, PhD, MPH,Laurel A. Habel, PhD,Sharon Hensley Alford, PhD,Catherine A. McCarty, PhD, MPH,Larissa Nekhlyudov, MD, MPH,Adedayo A. Onitilo, MD, MSCR, FACP,Alanna K. Rahm, PhD, MS,Jennifer A. Webster, MS

November 20th 2012

Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.

Latest Updated Articles

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study
Published: November 20th 2012 | Updated:

Jennifer A. Webster, MS

Articles by Jennifer A. Webster, MS

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study

Latest Updated Articles

Trending on AJMC

New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform

FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads

Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD

Medicare’s 3-Day Rule Reinstatement Lengthened Hospital Stays Without Cost, Outcome Benefits

Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps